Aradhana Sasan

Array ( [id] => 17828244 [patent_doc_number] => 20220265548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => ANIMAL TREAT COMPOSITION FOR DELIVERY OF ORAL MEDICATION [patent_app_type] => utility [patent_app_number] => 17/665372 [patent_app_country] => US [patent_app_date] => 2022-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16107 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17609663 [patent_doc_number] => 20220151942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-19 [patent_title] => MULTI-LAYERED CELL CAPSULES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/592313 [patent_app_country] => US [patent_app_date] => 2022-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16452 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17592313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19462327 [patent_doc_number] => 20240315996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => AN AQUEOUS GEL COMPOSITION COMPRISING AN ETHYLCELLULOSE [patent_app_type] => utility [patent_app_number] => 18/261679 [patent_app_country] => US [patent_app_date] => 2022-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2779 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17576805 [patent_doc_number] => 20220133660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-05 [patent_title] => METHODS OF TREATMENT USING SUSTAINED RELEASE SOTALOL FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/576687 [patent_app_country] => US [patent_app_date] => 2022-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10952 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17576687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17958518 [patent_doc_number] => 20220339098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/569047 [patent_app_country] => US [patent_app_date] => 2022-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8729 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17569047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19032345 [patent_doc_number] => 20240082160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => AMLODIPINE DRY SUSPENSION AND PREPARATION METHOD THEREFOR [patent_app_type] => utility [patent_app_number] => 18/272796 [patent_app_country] => US [patent_app_date] => 2021-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5173 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19637460 [patent_doc_number] => 12168056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-17 [patent_title] => Scintillator nanocrystal-containing compositions and methods for their use [patent_app_type] => utility [patent_app_number] => 17/564812 [patent_app_country] => US [patent_app_date] => 2021-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 35 [patent_no_of_words] => 33250 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17564812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19462293 [patent_doc_number] => 20240315962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => EXTENDED RELEASE COMPOSITIONS COMPRISING PYRIDOSTIGMINE [patent_app_type] => utility [patent_app_number] => 18/119477 [patent_app_country] => US [patent_app_date] => 2021-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50995 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18119477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19179877 [patent_doc_number] => 11986451 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-05-21 [patent_title] => Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics [patent_app_type] => utility [patent_app_number] => 17/530096 [patent_app_country] => US [patent_app_date] => 2021-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 80 [patent_figures_cnt] => 147 [patent_no_of_words] => 112360 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17530096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17458500 [patent_doc_number] => 20220071804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => BIO-ADHESIVE DISSOLVING COMPOUNDS AND DEVICE [patent_app_type] => utility [patent_app_number] => 17/528543 [patent_app_country] => US [patent_app_date] => 2021-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6835 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17528543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17414292 [patent_doc_number] => 20220049196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => LIQUID LOADING COMPOSITION, METHOD OF MAKING AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/452996 [patent_app_country] => US [patent_app_date] => 2021-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12515 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17452996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18901389 [patent_doc_number] => 20240016874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-18 [patent_title] => COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CORONAVIRUSES [patent_app_type] => utility [patent_app_number] => 18/034878 [patent_app_country] => US [patent_app_date] => 2021-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14011 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17576772 [patent_doc_number] => 20220133627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-05 [patent_title] => Stable Therapeutic Formulations [patent_app_type] => utility [patent_app_number] => 17/502701 [patent_app_country] => US [patent_app_date] => 2021-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13578 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17502701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18860258 [patent_doc_number] => 20230414692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => ETHANOLIC EXTRACT OF SEEDS OF SOLANUM MELONGENA, METHOD FOR OBTAINING IT, PHARMACEUTICAL COMPOSITION CONTAINING IT AND USE THEREOF AS AN ANTITUMOUR AGENT [patent_app_type] => utility [patent_app_number] => 18/248915 [patent_app_country] => US [patent_app_date] => 2021-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11989 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18245949 [patent_doc_number] => 11602512 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-03-14 [patent_title] => Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics [patent_app_type] => utility [patent_app_number] => 17/497381 [patent_app_country] => US [patent_app_date] => 2021-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 80 [patent_figures_cnt] => 147 [patent_no_of_words] => 103268 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18245950 [patent_doc_number] => 11602513 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-03-14 [patent_title] => Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics [patent_app_type] => utility [patent_app_number] => 17/497393 [patent_app_country] => US [patent_app_date] => 2021-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 80 [patent_figures_cnt] => 147 [patent_no_of_words] => 103341 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18012073 [patent_doc_number] => 11504347 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-11-22 [patent_title] => Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics [patent_app_type] => utility [patent_app_number] => 17/497366 [patent_app_country] => US [patent_app_date] => 2021-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 80 [patent_figures_cnt] => 147 [patent_no_of_words] => 103284 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20192259 [patent_doc_number] => 20250268969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-28 [patent_title] => OPHTHALMIC COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/251611 [patent_app_country] => US [patent_app_date] => 2021-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6767 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17426828 [patent_doc_number] => 20220054536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => NITRIC OXIDE TOPICAL APPLICATION APPARATUS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/494180 [patent_app_country] => US [patent_app_date] => 2021-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6933 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18784790 [patent_doc_number] => 20230372424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => ANTIVIRAL ACTIVE CINNAMON EXTRACT AND PROCESS [patent_app_type] => utility [patent_app_number] => 18/246911 [patent_app_country] => US [patent_app_date] => 2021-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5827 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246911 [rel_patent_id] =>[rel_patent_doc_number] =>)